Quantcast
Home > Quotes > SPPI
SPPI

Spectrum Pharmaceuticals, Inc.Common Stock (SPPI) Quote & Summary Data

$13.075
*  
0.355
2.79%
Get SPPI Alerts
*Delayed - data as of Nov. 21, 2018 11:03 ET  -  Find a broker to begin trading SPPI now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    SPPI Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 13.06 / $ 13.09
1 Year Target
31
Today's High / Low
$ 13.12 / $ 12.72
Share Volume
303,044
50 Day Avg. Daily Volume
1,523,568
Previous Close
$ 12.72
52 Week High / Low
$ 25.29 / $ 11.52
Market Cap
1,397,892,600
P/E Ratio
NE
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ -0.98
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
4.5

Intraday Chart

Shares Traded

Share Volume:
303,044
50 Day Avg. Daily Volume:
1,523,568

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.98

Trading Range

The current last sale of $13.075 is 13.50% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 13.12 $ 25.29
 Low: $ 12.72 $ 11.52

Company Description (as filed with the SEC)

Spectrum Pharmaceuticals, Inc. ("Spectrum", the "Company", "we", "our", or "us") is a biotechnology company, with a primary strategy comprised of acquiring, developing, and commercializing a broad and diverse pipeline of clinical and commercial products. We have an in-house clinical development organization with regulatory and data management capabilities, a commercial infrastructure and a field sales force for our marketed products. Currently, we have six approved oncology/hematology products (FUSILEV, FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ, and EVOMELA) that target different types of cancer including: non-Hodgkin's lymphoma, or NHL, advanced metastatic colorectal cancer, or mCRC, acute lymphoblastic leukemia, or ALL, and multiple myeloma, or MM.  ... More ...  


Risk Grade

Where does SPPI fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 12.89
Open Date:
Nov. 21, 2018
Close Price:
N/A
Close Date:
N/A

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x